Excelra Secures Leadership Position in Everest Group's Pharmaceutical R&D IT Services Assessment for 2026

Excelra Recognized as a Leader in Everest Group's Pharmaceutical R&D IT Services Assessment for 2026



Excelra, a prominent player in the life sciences data and informatics sector, has received notable recognition in Everest Group's Pharmaceutical R&D IT Services PEAK Matrix® Assessment for 2026. This prestigious assessment evaluated 34 service providers, and Excelra emerged as a leader based on its significant market influence, clear vision, and outstanding capabilities.

A Combination of Science and Technology


The assessment highlighted Excelra's strategic approach, blending robust data resources, advanced AI technologies, and specialized knowledge in the life sciences field. Key to this success is GOSTAR®, Excelra's flagship product containing over 37 million bioactivity data points, which is tailored for AI and machine learning applications. This product stands out as a critical enabler for drug discovery processes in the pharmaceutical industry.

Durga Ambati, a Vice President at Everest Group, remarked, "Pharmaceutical companies are increasingly seeking partners that offer a deep understanding of scientific and functional domains alongside strong data and AI capabilities. Excelra distinguishes itself with its proprietary datasets such as GOSTAR, which facilitates structure-activity relationship (SAR) intelligence for AI-assisted drug discovery. Moreover, their specialized AI solutions span multimodal data analytics and regulatory insights. These competencies have rightfully positioned Excelra at the forefront of the industry."

Commitment to Scientific Principles


Anandbir Brar, CEO of Excelra, emphasized the company's unwavering commitment to its scientific foundations, stating, "Science comes first. This principle is something we have always held dear, and this recognition is a testament to our dedication. In the realm of pharma R&D, having profound scientific expertise is just as crucial as having large-scale operations. As AI continues to evolve within R&D, it is essential for partners to merge knowledge of both science and technology."

Brar expressed gratitude for the trust clients place in Excelra, attributing the company's acknowledgment to the hard work and professionalism of its dedicated teams.

Strengthening Global Presence


To further enhance its offerings, Excelra has made strategic hires to bolster its onshore scientific consulting capabilities. These expansions allow Excelra to better serve its global clientele, ensuring proximity and responsiveness to their needs.

Excelra is also proud of its robust ecosystem of partnerships with leading cloud providers and technology firms, thereby enhancing its service delivery in lab informatics and broader technology platforms.

For those interested in a comprehensive view of Everest Group's assessment of Excelra, the report can be accessed at Excelra's official site.

About Excelra


Excelra specializes in harnessing AI-driven R&D strategies that integrate data-ready platforms, connected lab informatics, and expertise across various omics disciplines. This innovative approach aids organizations in navigating the complexities of R&D and making well-informed decisions. Visit www.excelra.com for more information.

About Everest Group


Everest Group is a leading research firm that equips business leaders with insights to navigate current market dynamics and enhance their strategies through tailored problem-solving approaches. More about their services can be found at www.everestgrp.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.